WNT6 and neoplasm: PLAGL2 combines with the WNT6 promoter and activates the β-catenin-dependent WNT signaling pathway, thereby stimulating various downstream target genes (such as MMP7, CCND1) and promoting tumor development (Li et al., 2019).